Erlotinib 24H post dose:MCnc:Pt:Ser/Plas:Qn:LC/MS/MS

Preferred Label : Erlotinib 24H post dose:MCnc:Pt:Ser/Plas:Qn:LC/MS/MS;

LOINC status : ACTIVE;

LOINC display name : Erlotinib 24 Hr post dose LC/MS/MS [Mass/Vol];

LOINC long common name : Erlotinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose;

LOINC short name : Erlotinib 24h p SerPl LC/MS/MS-mCnc;

LOINC description : A test referring to the sample being a trough plasma or serum sample in order to test for drugs taken once a day and the sample drawn 24 hours after the last dose.;

Details

Origin ID

103615-1;

UMLS CUI

C5885373;

Has challenge
- 24 hours post dose [LOINC Challenge]
- post dose [LOINC Challenge]
Has component
- Erlotinib [LOINC component]
- Erlotinib^24H post dose [LOINC component]
- dose [LOINC component]
- post [LOINC component]
Has method
- LC/MS/MS [LOINC method]
Has property
- Mass Concentration [LOINC Property]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients